000 | 01250 a2200373 4500 | ||
---|---|---|---|
005 | 20250513083254.0 | ||
264 | 0 | _c19960124 | |
008 | 199601s 0 0 eng d | ||
022 | _a0041-1337 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRemberger, M | |
245 | 0 | 0 |
_aIncreased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation. _h[electronic resource] |
260 |
_bTransplantation _cDec 1995 |
||
300 |
_a1293-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aBone Marrow Transplantation _xadverse effects |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGraft vs Host Disease _xblood |
650 | 0 | 4 |
_aHepatic Veno-Occlusive Disease _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterleukin-6 _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aReceptors, Interleukin-2 _xchemistry |
650 | 0 | 4 | _aSolubility |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTransplantation, Autologous |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
700 | 1 | _aRingdén, O | |
773 | 0 |
_tTransplantation _gvol. 60 _gno. 11 _gp. 1293-9 |
|
999 |
_c8524631 _d8524631 |